The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Tinea Corporis Treatment Market Research Report 2025

Global Tinea Corporis Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1724821

No of Pages : 85

Ask Your Query

Synopsis
Highlights
The global Tinea Corporis Treatment market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Tinea Corporis Treatment is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Tinea Corporis Treatment is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Tinea Corporis Treatment in Hospital Pharmacy is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Tinea Corporis Treatment include Perrigo Company, Taro Pharmaceuticals U.S.A., Inc., Teva Pharmaceuticals, Inc., Glenmark Pharmaceuticals Inc., Breckenridge Pharmaceutical, Inc., NorthStar Rx LLC, Aurobindo Pharma Limited, Camber Pharmaceuticals, Inc. and AvKare, Inc., etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Topical, which accounted for % of the global market of Tinea Corporis Treatment in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tinea Corporis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tinea Corporis Treatment.
The Tinea Corporis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Tinea Corporis Treatment market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tinea Corporis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Some of the prominent players reviewed in the research report include:

  • Perrigo Company
  • Taro Pharmaceuticals U.S.A., Inc.
  • Teva Pharmaceuticals, Inc.
  • Glenmark Pharmaceuticals Inc.
  • Breckenridge Pharmaceutical, Inc.
  • NorthStar Rx LLC
  • Aurobindo Pharma Limited
  • Camber Pharmaceuticals, Inc.
  • AvKare, Inc.
  • Novartis AG
  • Sebela Pharmaceuticals, Inc.
  • Bayer AG
  • Blueberry Therapeutics Ltd

Product Type Insights
Global markets are presented by Tinea Corporis Treatment type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Tinea Corporis Treatment are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Tinea Corporis Treatment segment by Type

  • Topical
  • Oral

Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Tinea Corporis Treatment market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Tinea Corporis Treatment market.
Tinea Corporis Treatment Segment by Application

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Tinea Corporis Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tinea Corporis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Tinea Corporis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Tinea Corporis Treatment industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tinea Corporis Treatment.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tinea Corporis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tinea Corporis Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Topical
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Tinea Corporis Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tinea Corporis Treatment Market Perspective (2017-2028)
2.2 Tinea Corporis Treatment Growth Trends by Region
2.2.1 Tinea Corporis Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Tinea Corporis Treatment Historic Market Size by Region (2017-2022)
2.2.3 Tinea Corporis Treatment Forecasted Market Size by Region (2023-2028)
2.3 Tinea Corporis Treatment Market Dynamics
2.3.1 Tinea Corporis Treatment Industry Trends
2.3.2 Tinea Corporis Treatment Market Drivers
2.3.3 Tinea Corporis Treatment Market Challenges
2.3.4 Tinea Corporis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tinea Corporis Treatment Players by Revenue
3.1.1 Global Top Tinea Corporis Treatment Players by Revenue (2017-2022)
3.1.2 Global Tinea Corporis Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Tinea Corporis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tinea Corporis Treatment Revenue
3.4 Global Tinea Corporis Treatment Market Concentration Ratio
3.4.1 Global Tinea Corporis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tinea Corporis Treatment Revenue in 2021
3.5 Tinea Corporis Treatment Key Players Head office and Area Served
3.6 Key Players Tinea Corporis Treatment Product Solution and Service
3.7 Date of Enter into Tinea Corporis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tinea Corporis Treatment Breakdown Data by Type
4.1 Global Tinea Corporis Treatment Historic Market Size by Type (2017-2022)
4.2 Global Tinea Corporis Treatment Forecasted Market Size by Type (2023-2028)
5 Tinea Corporis Treatment Breakdown Data by Application
5.1 Global Tinea Corporis Treatment Historic Market Size by Application (2017-2022)
5.2 Global Tinea Corporis Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Tinea Corporis Treatment Market Size (2017-2028)
6.2 North America Tinea Corporis Treatment Market Size by Country (2017-2022)
6.3 North America Tinea Corporis Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Tinea Corporis Treatment Market Size (2017-2028)
7.2 Europe Tinea Corporis Treatment Market Size by Country (2017-2022)
7.3 Europe Tinea Corporis Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tinea Corporis Treatment Market Size (2017-2028)
8.2 Asia-Pacific Tinea Corporis Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Tinea Corporis Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Tinea Corporis Treatment Market Size (2017-2028)
9.2 Latin America Tinea Corporis Treatment Market Size by Country (2017-2022)
9.3 Latin America Tinea Corporis Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tinea Corporis Treatment Market Size (2017-2028)
10.2 Middle East & Africa Tinea Corporis Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Tinea Corporis Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Perrigo Company
11.1.1 Perrigo Company Company Detail
11.1.2 Perrigo Company Business Overview
11.1.3 Perrigo Company Tinea Corporis Treatment Introduction
11.1.4 Perrigo Company Revenue in Tinea Corporis Treatment Business (2017-2022)
11.1.5 Perrigo Company Recent Development
11.2 Taro Pharmaceuticals U.S.A., Inc.
11.2.1 Taro Pharmaceuticals U.S.A., Inc. Company Detail
11.2.2 Taro Pharmaceuticals U.S.A., Inc. Business Overview
11.2.3 Taro Pharmaceuticals U.S.A., Inc. Tinea Corporis Treatment Introduction
11.2.4 Taro Pharmaceuticals U.S.A., Inc. Revenue in Tinea Corporis Treatment Business (2017-2022)
11.2.5 Taro Pharmaceuticals U.S.A., Inc. Recent Development
11.3 Teva Pharmaceuticals, Inc.
11.3.1 Teva Pharmaceuticals, Inc. Company Detail
11.3.2 Teva Pharmaceuticals, Inc. Business Overview
11.3.3 Teva Pharmaceuticals, Inc. Tinea Corporis Treatment Introduction
11.3.4 Teva Pharmaceuticals, Inc. Revenue in Tinea Corporis Treatment Business (2017-2022)
11.3.5 Teva Pharmaceuticals, Inc. Recent Development
11.4 Glenmark Pharmaceuticals Inc.
11.4.1 Glenmark Pharmaceuticals Inc. Company Detail
11.4.2 Glenmark Pharmaceuticals Inc. Business Overview
11.4.3 Glenmark Pharmaceuticals Inc. Tinea Corporis Treatment Introduction
11.4.4 Glenmark Pharmaceuticals Inc. Revenue in Tinea Corporis Treatment Business (2017-2022)
11.4.5 Glenmark Pharmaceuticals Inc. Recent Development
11.5 Breckenridge Pharmaceutical, Inc.
11.5.1 Breckenridge Pharmaceutical, Inc. Company Detail
11.5.2 Breckenridge Pharmaceutical, Inc. Business Overview
11.5.3 Breckenridge Pharmaceutical, Inc. Tinea Corporis Treatment Introduction
11.5.4 Breckenridge Pharmaceutical, Inc. Revenue in Tinea Corporis Treatment Business (2017-2022)
11.5.5 Breckenridge Pharmaceutical, Inc. Recent Development
11.6 NorthStar Rx LLC
11.6.1 NorthStar Rx LLC Company Detail
11.6.2 NorthStar Rx LLC Business Overview
11.6.3 NorthStar Rx LLC Tinea Corporis Treatment Introduction
11.6.4 NorthStar Rx LLC Revenue in Tinea Corporis Treatment Business (2017-2022)
11.6.5 NorthStar Rx LLC Recent Development
11.7 Aurobindo Pharma Limited
11.7.1 Aurobindo Pharma Limited Company Detail
11.7.2 Aurobindo Pharma Limited Business Overview
11.7.3 Aurobindo Pharma Limited Tinea Corporis Treatment Introduction
11.7.4 Aurobindo Pharma Limited Revenue in Tinea Corporis Treatment Business (2017-2022)
11.7.5 Aurobindo Pharma Limited Recent Development
11.8 Camber Pharmaceuticals, Inc.
11.8.1 Camber Pharmaceuticals, Inc. Company Detail
11.8.2 Camber Pharmaceuticals, Inc. Business Overview
11.8.3 Camber Pharmaceuticals, Inc. Tinea Corporis Treatment Introduction
11.8.4 Camber Pharmaceuticals, Inc. Revenue in Tinea Corporis Treatment Business (2017-2022)
11.8.5 Camber Pharmaceuticals, Inc. Recent Development
11.9 AvKare, Inc.
11.9.1 AvKare, Inc. Company Detail
11.9.2 AvKare, Inc. Business Overview
11.9.3 AvKare, Inc. Tinea Corporis Treatment Introduction
11.9.4 AvKare, Inc. Revenue in Tinea Corporis Treatment Business (2017-2022)
11.9.5 AvKare, Inc. Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Detail
11.10.2 Novartis AG Business Overview
11.10.3 Novartis AG Tinea Corporis Treatment Introduction
11.10.4 Novartis AG Revenue in Tinea Corporis Treatment Business (2017-2022)
11.10.5 Novartis AG Recent Development
11.11 Sebela Pharmaceuticals, Inc.
11.11.1 Sebela Pharmaceuticals, Inc. Company Detail
11.11.2 Sebela Pharmaceuticals, Inc. Business Overview
11.11.3 Sebela Pharmaceuticals, Inc. Tinea Corporis Treatment Introduction
11.11.4 Sebela Pharmaceuticals, Inc. Revenue in Tinea Corporis Treatment Business (2017-2022)
11.11.5 Sebela Pharmaceuticals, Inc. Recent Development
11.12 Bayer AG
11.12.1 Bayer AG Company Detail
11.12.2 Bayer AG Business Overview
11.12.3 Bayer AG Tinea Corporis Treatment Introduction
11.12.4 Bayer AG Revenue in Tinea Corporis Treatment Business (2017-2022)
11.12.5 Bayer AG Recent Development
11.13 Blueberry Therapeutics Ltd
11.13.1 Blueberry Therapeutics Ltd Company Detail
11.13.2 Blueberry Therapeutics Ltd Business Overview
11.13.3 Blueberry Therapeutics Ltd Tinea Corporis Treatment Introduction
11.13.4 Blueberry Therapeutics Ltd Revenue in Tinea Corporis Treatment Business (2017-2022)
11.13.5 Blueberry Therapeutics Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Tinea Corporis Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Topical
Table 3. Key Players of Oral
Table 4. Global Tinea Corporis Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Tinea Corporis Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Tinea Corporis Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Tinea Corporis Treatment Market Share by Region (2017-2022)
Table 8. Global Tinea Corporis Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Tinea Corporis Treatment Market Share by Region (2023-2028)
Table 10. Tinea Corporis Treatment Market Trends
Table 11. Tinea Corporis Treatment Market Drivers
Table 12. Tinea Corporis Treatment Market Challenges
Table 13. Tinea Corporis Treatment Market Restraints
Table 14. Global Tinea Corporis Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Tinea Corporis Treatment Market Share by Players (2017-2022)
Table 16. Global Top Tinea Corporis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tinea Corporis Treatment as of 2021)
Table 17. Ranking of Global Top Tinea Corporis Treatment Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Tinea Corporis Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Tinea Corporis Treatment Product Solution and Service
Table 21. Date of Enter into Tinea Corporis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tinea Corporis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Tinea Corporis Treatment Revenue Market Share by Type (2017-2022)
Table 25. Global Tinea Corporis Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Tinea Corporis Treatment Revenue Market Share by Type (2023-2028)
Table 27. Global Tinea Corporis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Tinea Corporis Treatment Revenue Market Share by Application (2017-2022)
Table 29. Global Tinea Corporis Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Tinea Corporis Treatment Revenue Market Share by Application (2023-2028)
Table 31. North America Tinea Corporis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Tinea Corporis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Tinea Corporis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Tinea Corporis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Tinea Corporis Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Tinea Corporis Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Tinea Corporis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Tinea Corporis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Tinea Corporis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Tinea Corporis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 41. Perrigo Company Company Detail
Table 42. Perrigo Company Business Overview
Table 43. Perrigo Company Tinea Corporis Treatment Product
Table 44. Perrigo Company Revenue in Tinea Corporis Treatment Business (2017-2022) & (US$ Million)
Table 45. Perrigo Company Recent Development
Table 46. Taro Pharmaceuticals U.S.A., Inc. Company Detail
Table 47. Taro Pharmaceuticals U.S.A., Inc. Business Overview
Table 48. Taro Pharmaceuticals U.S.A., Inc. Tinea Corporis Treatment Product
Table 49. Taro Pharmaceuticals U.S.A., Inc. Revenue in Tinea Corporis Treatment Business (2017-2022) & (US$ Million)
Table 50. Taro Pharmaceuticals U.S.A., Inc. Recent Development
Table 51. Teva Pharmaceuticals, Inc. Company Detail
Table 52. Teva Pharmaceuticals, Inc. Business Overview
Table 53. Teva Pharmaceuticals, Inc. Tinea Corporis Treatment Product
Table 54. Teva Pharmaceuticals, Inc. Revenue in Tinea Corporis Treatment Business (2017-2022) & (US$ Million)
Table 55. Teva Pharmaceuticals, Inc. Recent Development
Table 56. Glenmark Pharmaceuticals Inc. Company Detail
Table 57. Glenmark Pharmaceuticals Inc. Business Overview
Table 58. Glenmark Pharmaceuticals Inc. Tinea Corporis Treatment Product
Table 59. Glenmark Pharmaceuticals Inc. Revenue in Tinea Corporis Treatment Business (2017-2022) & (US$ Million)
Table 60. Glenmark Pharmaceuticals Inc. Recent Development
Table 61. Breckenridge Pharmaceutical, Inc. Company Detail
Table 62. Breckenridge Pharmaceutical, Inc. Business Overview
Table 63. Breckenridge Pharmaceutical, Inc. Tinea Corporis Treatment Product
Table 64. Breckenridge Pharmaceutical, Inc. Revenue in Tinea Corporis Treatment Business (2017-2022) & (US$ Million)
Table 65. Breckenridge Pharmaceutical, Inc. Recent Development
Table 66. NorthStar Rx LLC Company Detail
Table 67. NorthStar Rx LLC Business Overview
Table 68. NorthStar Rx LLC Tinea Corporis Treatment Product
Table 69. NorthStar Rx LLC Revenue in Tinea Corporis Treatment Business (2017-2022) & (US$ Million)
Table 70. NorthStar Rx LLC Recent Development
Table 71. Aurobindo Pharma Limited Company Detail
Table 72. Aurobindo Pharma Limited Business Overview
Table 73. Aurobindo Pharma Limited Tinea Corporis Treatment Product
Table 74. Aurobindo Pharma Limited Revenue in Tinea Corporis Treatment Business (2017-2022) & (US$ Million)
Table 75. Aurobindo Pharma Limited Recent Development
Table 76. Camber Pharmaceuticals, Inc. Company Detail
Table 77. Camber Pharmaceuticals, Inc. Business Overview
Table 78. Camber Pharmaceuticals, Inc. Tinea Corporis Treatment Product
Table 79. Camber Pharmaceuticals, Inc. Revenue in Tinea Corporis Treatment Business (2017-2022) & (US$ Million)
Table 80. Camber Pharmaceuticals, Inc. Recent Development
Table 81. AvKare, Inc. Company Detail
Table 82. AvKare, Inc. Business Overview
Table 83. AvKare, Inc. Tinea Corporis Treatment Product
Table 84. AvKare, Inc. Revenue in Tinea Corporis Treatment Business (2017-2022) & (US$ Million)
Table 85. AvKare, Inc. Recent Development
Table 86. Novartis AG Company Detail
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Tinea Corporis Treatment Product
Table 89. Novartis AG Revenue in Tinea Corporis Treatment Business (2017-2022) & (US$ Million)
Table 90. Novartis AG Recent Development
Table 91. Sebela Pharmaceuticals, Inc. Company Detail
Table 92. Sebela Pharmaceuticals, Inc. Business Overview
Table 93. Sebela Pharmaceuticals, Inc. Tinea Corporis TreatmentProduct
Table 94. Sebela Pharmaceuticals, Inc. Revenue in Tinea Corporis Treatment Business (2017-2022) & (US$ Million)
Table 95. Sebela Pharmaceuticals, Inc. Recent Development
Table 96. Bayer AG Company Detail
Table 97. Bayer AG Business Overview
Table 98. Bayer AG Tinea Corporis TreatmentProduct
Table 99. Bayer AG Revenue in Tinea Corporis Treatment Business (2017-2022) & (US$ Million)
Table 100. Bayer AG Recent Development
Table 101. Blueberry Therapeutics Ltd Company Detail
Table 102. Blueberry Therapeutics Ltd Business Overview
Table 103. Blueberry Therapeutics Ltd Tinea Corporis TreatmentProduct
Table 104. Blueberry Therapeutics Ltd Revenue in Tinea Corporis Treatment Business (2017-2022) & (US$ Million)
Table 105. Blueberry Therapeutics Ltd Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tinea Corporis Treatment Market Share by Type: 2021 VS 2028
Figure 2. Topical Features
Figure 3. Oral Features
Figure 4. Global Tinea Corporis Treatment Market Share by Application in 2021 & 2028
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Retail Pharmacy Case Studies
Figure 7. Others Case Studies
Figure 8. Tinea Corporis Treatment Report Years Considered
Figure 9. Global Tinea Corporis Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Tinea Corporis Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Tinea Corporis Treatment Market Share by Region: 2021 VS 2028
Figure 12. Global Tinea Corporis Treatment Market Share by Players in 2021
Figure 13. Global Top Tinea Corporis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tinea Corporis Treatment as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Tinea Corporis Treatment Revenue in 2021
Figure 15. North America Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Tinea Corporis Treatment Market Share by Country (2017-2028)
Figure 17. United States Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Tinea Corporis Treatment Market Share by Country (2017-2028)
Figure 21. Germany Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Tinea Corporis Treatment Market Share by Region (2017-2028)
Figure 29. China Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Tinea Corporis Treatment Market Share by Country (2017-2028)
Figure 37. Mexico Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Tinea Corporis Treatment Market Share by Country (2017-2028)
Figure 41. Turkey Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Tinea Corporis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Perrigo Company Revenue Growth Rate in Tinea Corporis Treatment Business (2017-2022)
Figure 44. Taro Pharmaceuticals U.S.A., Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2017-2022)
Figure 45. Teva Pharmaceuticals, Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2017-2022)
Figure 46. Glenmark Pharmaceuticals Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2017-2022)
Figure 47. Breckenridge Pharmaceutical, Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2017-2022)
Figure 48. NorthStar Rx LLC Revenue Growth Rate in Tinea Corporis Treatment Business (2017-2022)
Figure 49. Aurobindo Pharma Limited Revenue Growth Rate in Tinea Corporis Treatment Business (2017-2022)
Figure 50. Camber Pharmaceuticals, Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2017-2022)
Figure 51. AvKare, Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2017-2022)
Figure 52. Novartis AG Revenue Growth Rate in Tinea Corporis Treatment Business (2017-2022)
Figure 53. Sebela Pharmaceuticals, Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2017-2022)
Figure 54. Bayer AG Revenue Growth Rate in Tinea Corporis Treatment Business (2017-2022)
Figure 55. Blueberry Therapeutics Ltd Revenue Growth Rate in Tinea Corporis Treatment Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock